P. Theil

Molecular Biology · 2011–2018

A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom P. Theil trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. P. Carter (in Molecular Biology)

Papers from P. Theil's perspective

Ordered by how strongly the researchers P. Theil trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Potent antibody therapeutics by design (Nature reviews. Immunology)
  2. Gut flora in health and disease. (The Lancet)
  3. Host-Bacterial Mutualism in the Human Intestine (Science)
  4. Selecting and screening recombinant antibody libraries (Nature Biotechnology)
  5. The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular… (Journal of Biological Chemistry)
  6. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. (Blood)
  7. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. (Gastroenterology)
  8. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. (Arthritis & Rheumatism)
  9. Antibody pharmacokinetics and pharmacodynamics. (Journal of Pharmacy and Science)
  10. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary… (Arthritis & Rheumatism)

Their papers